Invention Grant
- Patent Title: Compounds and compositions useful for treating disorders related to NTRK
-
Application No.: US16527773Application Date: 2019-07-31
-
Publication No.: US11059827B2Publication Date: 2021-07-13
- Inventor: Steven Mark Wenglowsky , Chandrasekhar V. Miduturu , Neil Bifulco , Joseph L. Kim
- Applicant: Blueprint Medicines Corporation
- Applicant Address: US MA Cambridge
- Assignee: Blueprint Medicines Corporation
- Current Assignee: Blueprint Medicines Corporation
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Wei Song
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/02
Abstract:
This invention relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants.
Public/Granted literature
- US20190382410A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK Public/Granted day:2019-12-19
Information query
